GB1170059A - Biologically Active Compositions containing Aminopolyamide Resins - Google Patents
Biologically Active Compositions containing Aminopolyamide ResinsInfo
- Publication number
- GB1170059A GB1170059A GB55815/66A GB5581566A GB1170059A GB 1170059 A GB1170059 A GB 1170059A GB 55815/66 A GB55815/66 A GB 55815/66A GB 5581566 A GB5581566 A GB 5581566A GB 1170059 A GB1170059 A GB 1170059A
- Authority
- GB
- United Kingdom
- Prior art keywords
- biologically active
- weight
- active substance
- resin
- amine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920005989 resin Polymers 0.000 title abstract 6
- 239000011347 resin Substances 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 3
- 229940088623 biologically active substance Drugs 0.000 abstract 4
- 150000001412 amines Chemical class 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 2
- VIROVYVQCGLCII-UHFFFAOYSA-N amobarbital Chemical compound CC(C)CCC1(CC)C(=O)NC(=O)NC1=O VIROVYVQCGLCII-UHFFFAOYSA-N 0.000 abstract 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- -1 ethylene, propylene, tetramethylene Chemical group 0.000 abstract 2
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 abstract 2
- 229930182817 methionine Natural products 0.000 abstract 2
- 150000003431 steroids Chemical class 0.000 abstract 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 abstract 2
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 abstract 1
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 abstract 1
- BJPDIGBWPYFJEO-UHFFFAOYSA-N 5-(cyclopenten-1-yl)-1,3-diazinane-2,4,6-trione Chemical compound O=C1NC(=O)NC(=O)C1C1=CCCC1 BJPDIGBWPYFJEO-UHFFFAOYSA-N 0.000 abstract 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
- 108010001478 Bacitracin Proteins 0.000 abstract 1
- 229940123208 Biguanide Drugs 0.000 abstract 1
- 235000010469 Glycine max Nutrition 0.000 abstract 1
- 244000068988 Glycine max Species 0.000 abstract 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 abstract 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- 239000004100 Oxytetracycline Substances 0.000 abstract 1
- 241000282849 Ruminantia Species 0.000 abstract 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 abstract 1
- 229940100389 Sulfonylurea Drugs 0.000 abstract 1
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
- 125000003368 amide group Chemical group 0.000 abstract 1
- 229940098184 amytal Drugs 0.000 abstract 1
- 230000001548 androgenic effect Effects 0.000 abstract 1
- 230000000507 anthelmentic effect Effects 0.000 abstract 1
- 229940124339 anthelmintic agent Drugs 0.000 abstract 1
- 239000000921 anthelmintic agent Substances 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 230000002921 anti-spasmodic effect Effects 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 229940125716 antipyretic agent Drugs 0.000 abstract 1
- 229940124575 antispasmodic agent Drugs 0.000 abstract 1
- 229960003071 bacitracin Drugs 0.000 abstract 1
- 229930184125 bacitracin Natural products 0.000 abstract 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 abstract 1
- 150000004283 biguanides Chemical class 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 abstract 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 abstract 1
- 230000001076 estrogenic effect Effects 0.000 abstract 1
- 239000003172 expectorant agent Substances 0.000 abstract 1
- 230000003419 expectorant effect Effects 0.000 abstract 1
- 229940066493 expectorants Drugs 0.000 abstract 1
- 229960004198 guanidine Drugs 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229960000890 hydrocortisone Drugs 0.000 abstract 1
- 229940126904 hypoglycaemic agent Drugs 0.000 abstract 1
- 239000008141 laxative Substances 0.000 abstract 1
- 229940125722 laxative agent Drugs 0.000 abstract 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract 1
- 235000020778 linoleic acid Nutrition 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 244000005706 microflora Species 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 229960000625 oxytetracycline Drugs 0.000 abstract 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 abstract 1
- 235000019366 oxytetracycline Nutrition 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 abstract 1
- 229960002695 phenobarbital Drugs 0.000 abstract 1
- 229950000688 phenothiazine Drugs 0.000 abstract 1
- 150000004986 phenylenediamines Chemical class 0.000 abstract 1
- 150000004885 piperazines Chemical class 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 239000000376 reactant Substances 0.000 abstract 1
- 210000004767 rumen Anatomy 0.000 abstract 1
- 229940125723 sedative agent Drugs 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 229960004025 sodium salicylate Drugs 0.000 abstract 1
- QGMRQYFBGABWDR-UHFFFAOYSA-N sodium;5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)NC1=O QGMRQYFBGABWDR-UHFFFAOYSA-N 0.000 abstract 1
- 229960005322 streptomycin Drugs 0.000 abstract 1
- 229960002135 sulfadimidine Drugs 0.000 abstract 1
- ASWVTGNCAZCNNR-UHFFFAOYSA-N sulfamethazine Chemical compound CC1=CC(C)=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ASWVTGNCAZCNNR-UHFFFAOYSA-N 0.000 abstract 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- 229920003002 synthetic resin Polymers 0.000 abstract 1
- 239000000057 synthetic resin Substances 0.000 abstract 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 abstract 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 abstract 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
- A23K40/35—Making capsules specially adapted for ruminants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Fodder In General (AREA)
- Polyamides (AREA)
- Medicinal Preparation (AREA)
- Feed For Specific Animals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51323265A | 1965-12-13 | 1965-12-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1170059A true GB1170059A (en) | 1969-11-12 |
Family
ID=24042392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB55815/66A Expired GB1170059A (en) | 1965-12-13 | 1966-12-13 | Biologically Active Compositions containing Aminopolyamide Resins |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3511907A (pm) |
| BE (1) | BE691086A (pm) |
| BR (1) | BR6685282D0 (pm) |
| CH (1) | CH481586A (pm) |
| DE (1) | DE1692461A1 (pm) |
| ES (1) | ES334329A1 (pm) |
| GB (1) | GB1170059A (pm) |
| NL (1) | NL6617303A (pm) |
| NO (1) | NO120058B (pm) |
| OA (1) | OA02285A (pm) |
| SE (1) | SE335943B (pm) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EG10802A (en) * | 1971-02-19 | 1976-10-31 | Bayer Ag | A process for embeding veterinary substances and their protection against the influence of the gastric juice of the rumen |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3242141A (en) * | 1962-12-04 | 1966-03-22 | Gen Mills Inc | Polyamide compositions from fatty dimer diamines |
| US3231545A (en) * | 1962-01-02 | 1966-01-25 | Gen Mills Inc | Polyamides from fatty dimer diamines and process of preparing same |
-
1965
- 1965-12-13 US US513232A patent/US3511907A/en not_active Expired - Lifetime
-
1966
- 1966-12-09 ES ES0334329A patent/ES334329A1/es not_active Expired
- 1966-12-09 NL NL6617303A patent/NL6617303A/xx unknown
- 1966-12-12 BE BE691086D patent/BE691086A/xx unknown
- 1966-12-12 SE SE17020/66A patent/SE335943B/xx unknown
- 1966-12-12 NO NO165967A patent/NO120058B/no unknown
- 1966-12-12 OA OA52691A patent/OA02285A/xx unknown
- 1966-12-12 BR BR185282/66A patent/BR6685282D0/pt unknown
- 1966-12-12 DE DE19661692461 patent/DE1692461A1/de active Pending
- 1966-12-13 CH CH1774866A patent/CH481586A/de not_active IP Right Cessation
- 1966-12-13 GB GB55815/66A patent/GB1170059A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CH481586A (de) | 1969-11-30 |
| SE335943B (pm) | 1971-06-14 |
| NL6617303A (pm) | 1967-06-14 |
| ES334329A1 (es) | 1967-10-16 |
| OA02285A (fr) | 1970-05-05 |
| BR6685282D0 (pt) | 1973-12-27 |
| DE1692461A1 (de) | 1972-04-13 |
| NO120058B (pm) | 1970-08-17 |
| US3511907A (en) | 1970-05-12 |
| BE691086A (pm) | 1967-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3655864A (en) | Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption | |
| US3862333A (en) | Methods and compositions for inhibiting rumen microbial deamination | |
| DK367687A (da) | Farmaceutisk praeparat til oral indgift med reguleret afgivelse og forlaenget virkning | |
| FR2655266B1 (fr) | Compositions pharmaceutiques a base de cimetidine. | |
| AR024441A1 (es) | Agonistas del receptor a2a n-pirazol, composiciones farmaceuticas y el uso de los mismos para preparar un medicamento. | |
| GB1283054A (en) | Improvements in and relating to delayed release veterinary and pharmaceutical compositions | |
| ATE128863T1 (de) | Arzneimittelformulierungen mit verzögerter wirkstoffabgabe. | |
| MX9301246A (es) | Metodos y aparatos para suministro de droga usando soluciones supercriticas. | |
| IT1251153B (it) | Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica | |
| GB1381872A (en) | Pharmaceutical compositions for inhalation | |
| GR850714B (pm) | ||
| SE7407325L (pm) | ||
| DE69217658D1 (de) | Medetomidine zusammensetzungen für die transdermale verabreichung | |
| GB2006009A (en) | Medicinal or nutrient pellets for oral administration to ruminants | |
| GB1156010A (en) | Polyamide Compositions comprising Biologically Active Substances | |
| GB1170059A (en) | Biologically Active Compositions containing Aminopolyamide Resins | |
| ES8801803A1 (es) | Procedimiento para preparar derivados de cinalina. | |
| GB1073627A (en) | Polyamide resins | |
| GB934089A (en) | Improvements in or relating to sustained release medicaments | |
| GB1389437A (en) | 1,4-benzodiazepine derivatives and their preparation | |
| FR2081436B1 (pm) | ||
| US3697659A (en) | Amine containing animal feed compositions | |
| GB1160936A (en) | Veterinary Preparations for Ruminants having a Coating inert to the Rumen | |
| DE69830305D1 (de) | Ortsspezifische arzneimittel verabreichung | |
| GB1351437A (en) | N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity |